Bio Key International (BKYI) Liabilities and Shareholders Equity (2010 - 2026)

Bio Key International has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $8.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 27.06% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.1 million (up 19.65% YoY) and the FY2025 annual result came in at $8.3 million, down 3.62% from the prior year.
• Liabilities and Shareholders Equity declined to $8.2 million in Q1 2026 per BKYI's latest filing, from $8.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $19.4 million in Q1 2022 and troughed at $4.2 million in Q1 2024.
• A 5-year average of $9.6 million and a median of $8.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity plunged 60.41% in 2023, then jumped 168.26% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $11.3 million in 2022, then plunged by 60.18% to $4.5 million in 2023, then surged by 90.73% to $8.6 million in 2024, then fell by 3.62% to $8.3 million in 2025, then decreased by 1.76% to $8.2 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $8.2 million, $8.3 million, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.